J'NELLE RUSCETTI: Open Payments
NPI 1730275793 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 11 payments from 7 companies in 2025. Trend: 2023 $175 · 2024 $113 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Abbott Laboratories | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Wegovy, TZIELD, XIFAXAN, FREESTYLE LIBRE 3, ELIQUIS, SHINGRIX, BREZTRI, FARXIGA.
Industry payments across NC — which companies pay providers there.
